Abstract To review the outcomes of laser supraglottoplasty performed in children with symptomatic laryngomalacia and determine the factors influencing them. We retrospectively reviewed the medical records of patients who underwent laser supraglottoplasty for symptomatic laryngomalacia at the Lausanne University Hospital from November 2001 to November 2014. We examined the patient's demography, symptoms, comorbidities, type of laryngomalacia, synchronous airway lesions, and final outcomes. Seventy-nine patients were included in this study; median age at the time of surgery was 12.7 months. 55.7 % of the cases had comorbidities, 22.8 % of the patients were premature and synchronous airway lesions were present in 32.9 % of the cases. The different morphological types of laryngomalacia (I-III) were seen in 26.6, 62 and 11.4 % of the patients, respectively. Overall, operation specific success rate of laser supraglottoplasty was 86.1 %. Failures in 11 (13.9 %) of the 79 cases required 15 revision procedures. Success rates for patients with associated comorbidities, synchronous airway lesions, neurological disorders and prematurity were 81.8, 76.9, 69.2 and 66.7 %, respectively. Patients with type III laryngomalacia had a limited success rate (66.7 %) as compared to patients with morphological types I and II (90.5 and 87.8 %, respectively). Laser supraglottoplasty is an effective and safe treatment for symptomatic laryngomalacia. Patients with prematurity, type III LM, synchronous airway lesions and associated comorbidities are predisposed to surgical failure.
Introduction
Laryngomalacia (LM) is the most common cause of stridor in infants and represents almost 60-70 % of all congenital laryngeal anomalies [1] . It is characterized by a dynamic obstruction of the upper airway caused by an inward collapse of supraglottic structures during inspiration resulting in an inspiratory stridor [2] . The exact pathophysiology of LM remains unclear, and several theories have been proposed to explain its etiology [3] [4] [5] . The neurological theory, which is actually the most widely accepted, suggests a neurosensory dysfunction leading to poor neuromuscular coordination of the supraglottic airway. This theory comes from the observation of increased laryngopharyngeal sensory thresholds in patients with LM [5] , indicating that peripheral afferent function of laryngeal sensation is altered. Gastroesophageal reflux disease (GERD) has also been suspected to cause LM as GERD is observed in about 70-80 % of cases [6] . The proposed mechanism indicating the role of GERD results secondarily from an increased negative pressure needed to overcome the upper airway obstruction caused by LM. However, a systematic review of the literature has not found a direct causal relationship between the two entities [7] .
Several classifications of LM have been proposed depending on the subsite of laryngeal involvement [2, [8] [9] [10] [11] [12] , but none have been universally adopted. Olney and colleagues described three types of LM depending on the supraglottic morphology [9] . Type I is characterized by prolapsing supra arytenoid floppy tissues, type II by shortened aryepiglottic folds associated with a long tubular epiglottis that curls on itself and type III by an overhanging retroflexed epiglottis that collapses posteriorly during inspiration (Fig. 1) .
Symptoms usually appear within the first weeks of life, progress to a peak around 2-5 months and resolve before 2 years of age [5, 13] . LM induced inspiratory stridor typically gets worse during increased air demands. Ten to 20 % of cases present with severe symptoms requiring endoscopic supraglottplasty (SGP) [5, 14, 15] . The indicators of severe LM requiring surgical correction are: stridor with dyspnea and suprasternal/intercostal retractions, hypoxia, apneic spells, recurrent cyanosis, feeding difficulties with failure to thrive and cor pulmonale [4, 8] . The success rate of SGP varies between 60 and 95 % [8, 10, 16] , with patients suffering from comorbidities such as congenital anomalies, neurologic pathologies, prematurity and obesity having poorer outcomes [17] [18] [19] [20] [21] [22] .
In case of severe LM, a systematic dynamic airway endoscopy is required to confirm the clinical diagnosis, characterize the morphological type of LM, rule out other associated anomalies and decide the kind of SGP that needs to be performed. Diagnosis and surgical correction of LM are performed during the same general anesthesia.
In this article, we review the outcomes of laser supraglottoplasty (LSGP) performed at a tertiary referral center for children with severe symptomatic LM, and we discuss the factors influencing these outcomes.
Materials and methods
After institutional review board approval, we retrospectively analyzed the medical records of patients who underwent LSGP for symptomatic LM at the Lausanne University Hospital from November 2001 to November 2014. The diagnosis of LM was based on clinical presentation and confirmed by a transnasal fiberoptic laryngoscopy (TNFL) under general anesthesia and the patient breathing spontaneously allowing a dynamic upper airway evaluation. Flexible bronchoscopy, rigid laryngo-tracheoscopy and oesophagoscopy were performed during the same procedure to rule out synchronous upper airway and reflux-induced lesions. The supraglottic obstruction was classified according to Olney's classification [9] to determine the morphological type of LM (Fig. 1) .
Indications for LSGP were: severe LM with inspiratory stridor, dyspnea with chest retractions, oxygen desaturations, cyanosis, obstructive apneas, feeding difficulties with or without failure to thrive and presence of a tracheostomy due to severe laryngomalacia. All LSGP were performed by senior surgeons under general anesthesia and successive apnea technique. The larynx was exposed by a suspension laryngoscope (Benjamin-Lindholm laryngoscope, Storz, Germany) inserted into the valleculae permitting an axial, panoramic and symmetrical exposure of the supraglottic structures. Intermittent translaryngeal intubation was done through the suspension laryngoscope by inserting 3.0/3.5 portex blue line endotracheal tube with the help of laryngeal forceps under direct vision. The procedure was performed using the CO 2 laser (Ultra Pulse Surgi Touch CO 2 laser, Lumenis, Israel) connected to a microscope (Leica, Germany) and a micro- Fig. 1 Morphological types of laryngomalacia (LM) classified according to Olney's classification: Type I LM: prolapsing supra arytenoid floppy tissues, Type II LM: shortened aryepiglottic folds associated with a long, omega-shape epiglottis that curls on itself, Type III LM: overhanging retroflexed epiglottis collapsing posteriorly during inspiration manipulator (Clearspot 160/400 mm, Coherent, USA) allowing a very precise and bloodless resection. The laser parameters used were: ultrapulse mode, 125 mJ/cm 2 and 250 microspot. In type I LM, the excess floppy arytenoid mucosa, corniculate and cuneiform cartilages were partially resected and/or vaporized. For type II LM, the shortened aryepiglottic folds were sectioned and the lateral edges of the epiglottis resected. In addition, floppy supraglottic tissues were partially resected and/or vaporized (Fig. 2) .
Endoscopic epiglottopexy was performed for type III LM. This consisted of using the CO 2 laser (continuous working mode, 3 Watts) and performing mucosal fulguration of the tongue base, valleculae and lingual aspect of the epiglottis. The epiglottopexy was done by passing two or three transoral resorbable sutures (3.0 Vicryl) through the epiglottis and as deep as possible into the musculature of the tongue base (Fig. 3) .
We noted patients demography, pre-and post-operative symptoms, clinical signs, comorbidities (neurologic, prematurity, synchronous airway lesions SAL, GERD), morphological types of LM, type of SGP performed, duration of stay in intensive care unit, total hospital stay, complications and finally the necessity and type of revision surgery, if performed.
Operation specific success rate (OSSR) was defined as complete resolution of the initial symptoms or definitive symptom improvement without the need for further intervention. Failure was defined as insufficient improvement of the initial symptoms requiring further intervention (revision surgery, prolonged non-invasive ventilation and oxygen therapy, tracheotomy). Statistical analysis was done using the Fisher's exact test.
Results
Seventy-nine patients were included in this study. There were 44 boys (55.7 %) and 35 girls (44.3 %), and the mean age of performing SGP was 12.7 months (m) (range 1-137 m). The most common presenting symptoms and indications for SGP were stridor (93.7 %), chest retractions (69.6 %), feeding difficulties/failure to thrive (43 %) and desaturations/cyanosis/apnea (27.8 %). Five patients (6.3 %) were already tracheotomised and transferred to our hospital for further management. The morphological types of LM I-III were seen in 26.6, 62 and 11.4 % patients, respectively. Post-surgery extubation was possible in the operating theater in 82.3 % of cases. With increasing experience of our team, we observed that it is almost always possible to extubate the patient in the operating theater (54 of the last 56 consecutive cases) provided that no major comorbidities are present. All patients were transferred to the intensive care unit with continuous positive airway pressure (CPAP) that was gradually weaned off. The mean duration of stay in the intensive care unit was 45.4 h (h) (0-360 h) and the mean hospital stay was 7.78 days (d) (1-130 days).
Surgical complications occurred in six patients (7.6 %): three patients experienced a complete breakdown after epiglottopexy with relapse of type III LM (all three patients had a revision epiglottopexy with good results), two patients presented with poor healing and scar tissue formation between the free edge of the epiglottis and the pharyngo-epiglottic folds after LSGP for type II LM (both patients had minimal feeding difficulties that improved over time) and one patient developed subglottic stenosis due to prolonged intubation after post-operative pneumonia. This patient underwent a partial cricotracheal resection with a favorable outcome.
LSGP outcomes were as follows: 73.4 % of patients had complete resolution of their initial symptoms, 16.5 % of patients had improvement and 10.1 % had persistence of initial symptoms with a mean follow up of 4.7 months (m) (range 1-39 m). Operation specific success rate (OSSR) for all patients was 86.1 % (68/79 patients). Eleven patients underwent one or more revision surgeries (total 15 revision procedures). Revision procedures were LSGP (four patients with type I LM and two patients with type II LM) and epiglottopexy in nine patients. After revision surgery, five patients had complete resolution of their symptoms, five had significant improvement and one had persistence of his symptoms. Forty-four patients (55.7 %) had associated comorbidities: 13 patients (16.5 %) had neurological comorbidities, 26 patients (32.9 %) patients had SAL, 18 patients (22.8 %) were born prematurely and 33 patients (41.8 %) suffered from severe GERD.
Operation specific success rates (OSSR) for the different types of LM (type I-III) were 90.5 % (19/21), 87.8 % (43/ 49) and 66.7 % (6/9), respectively. The OSSR for patients with comorbidities was 81.8 % (36/44) as compared to 91.4 % (32/35) for patients without comorbidities. OSSR for patients with comorbidities was 66.7 % (12/18) in premature patients, 69.2 % (9/13) in patients with neurological comorbidities, 76.9 % (20/26) in patients with SAL and 78.8 % (26/33) in patients with GERD. Using onesided Fisher's exact test to evaluate the OSSR after LSGP, the only factor that showed statistical significance was prematurity (p = 0.014) ( Table 1) .
When patients were analyzed according to the morphological type of LM (Table 2) Post-operative complications were found in 3/9 (33.3 %) patients with type III LM, 3/49 (6.1 %) with type II LM and none in patients with type I.
Comorbidities were present in 88.9 % (8/9) patients with type III LM, 52.4 % (11/21) patients with type I LM and 51.0 % (25/49) with type II LM. In the subset of patients with type III LM, SAL were seen in 88.9 % (8/9) patients, neurological comorbidities in 33.3 % (3/9 patients), prematurity in 55.6 % (5/9 patients) and GERD in 44.4 % (4/9 patients). These associations were considerably lower in LM I and II (Table 2 ).
Discussion
Our series confirms that LSGP is safe and efficient in severe and symptomatic cases of LM as has been demonstrated in multiple studies [10, 23] . Nevertheless, certain patients presenting with comorbidities such as congenital anomalies, neurological pathologies, prematurity and synchronous airway lesions SAL have less favorable outcomes and more complications. This confirms the findings of previously published works [17, 24] . Numerous classifications of LM exist [2, [8] [9] [10] [11] [12] , but few studies [13, 14, 17, 29] have analyzed the outcomes of SGP according to the morphological type of LM.
Our case series included morphological types I, II and III of LM, in 26.6, 62 and 11.4 % of cases, respectively, according to Olneys' classification [9] . The success rate of LSGP for type III was lower (66.7 %, 6/9 patients) than for type I (90.5 %, 19/21) and type II (87.8 %, 43/49). To our knowledge, this is the first report indicating that the morphological type of LM seems to be an independent risk factor for the success or failure after LSGP. Of course, these observations and results need to be confirmed by further prospective studies involving more patients with a multivariate analysis. Olney's classification is practical and surgically relevant. The surgical intervention differs as per the morphological type of LM. In types I and II, the surgery reduces the redundant supra arytenoid tissues, and corrects the short aryepiglottic folds. In type III LM, the epiglottis needs to be attached to the tongue base to avoid its prolapse into the airway. We found a high rate of pexy breakdown (3 out of 9 cases) after epiglottopexy done conventionally in the earlier part of our study. To resolve this issue, we have developed a new technique for epiglottopexy using the Lichtenberger's needle-carrier (LNC) [25] , that allows making deeper pexy sutures that are less prone to break down. Under suspension laryngoscopy, a laser-assisted mucosal fulguration of the valleculae and the base of tongue is performed. Then, transfixating sutures are placed transorally between the base of tongue and epiglottis using the LNC. The resorbable sutures are buried in the subcutaneous tissue by a separate external mini skin incision. These glosso-epiglottic sutures are deep enough into the tongue base to successfully fix the epiglottis and keep the laryngeal inlet open (Fig. 4) . This technique was not applied to the patients described here but it has recently become the standard procedure for epiglottopexy in our clinic (5 cases in 2015 with 100 % success rate). We believe that in the past treatment for type III LM, the nontransfixant pexy sutures were placed too superficially into the tongue base, and this played an important role in the high failure rate seen. With this new epiglottopexy technique, none of our patients had any neurovascular complications of the tongue or experienced chronic intractable bronchoaspiration.
We also note that patients with type III LM are associated with more comorbidities such as SAL, prematurity and neurological conditions that may have required preoperative tracheotomy (5/9) in comparison to patients with types I and II (Table 2 ). Needless to say that, these associations played an important role in the poor final result outcomes.
SALs are adverse prognostic indicators as already observed by Schroeder et al. [24] . In our study, there were 26 patients (32.9 %) suffering from concomitant SALs, which is higher than in most published studies to date [24, [26] [27] [28] . This may be explained, by the fact that our clinic treats several patients from foreign countries referred for the treatment of complex airway pathologies and in particular for glotto-subglottic stenoses (GSGS) and consequently our cases often have multiple SALs-which need correction before definitive stenoses treatment. Advanced age of presentation may also be related to the delayed referral of these patients. Additionally, all these patients had dedicated and systematic pre-operative endoscopic work-up (dynamic transnasal flexible bronchoscopy, direct laryngo-tracheoscopy and oesophagoscopy) that allowed better diagnosis of these additional pathologies that were previously missed.
In our study, 44 patients (55.7 %) presented with comorbidities and showed a lower success rate after SGP and this confirms previously published results [19, 23] . The success rate of LSGP in premature patients (66.7 %, 12/18), is significantly lower than the overall success rate in the present series (p = 0.014). This confirms that prematurity is an unfavorable prognostic factor for SGP, and this is in agreement with the literature [10, 18, 23, 24, 29] .
The success rate in cases of associated GERD (44 patients) was 81.8 % (36/44), which is lower than our overall success rate. This may be explained in part by the persistent pharyngolaryngeal inflammation despite aggressive pre-operative treatment. In the present series, diagnosis of GERD was based on symptoms and confirmed during oesophagoscopy. Pre-treatment of pH-metry is more sensitive and specific in GERD diagnosis, but was not performed in our patients.
Concerning SGP failures, 11 patients needed at least one salvage operation with 15 revision procedures in total. Of the 15 salvage procedures-nine were epiglottopexies and six were supraglottoplasties. An either too conservative or too aggressive excision of the supraglottic tissues leads to recurrence of symptoms. Indeed, symptoms are bound to recur if the causative redundant tissues are insufficiently removed. When too much tissue is excised, aryepiglottic folds are replaced by fibrocicatrical tissue that pulls the epiglottis downwards further blocking the laryngeal inlet and may transform into more dreaded supraglottic stenosis. In such salvage re-do endoscopic surgeries, it is critical to perform: (a) an epiglottopexy using the Lichtenberger's needle-carrier and (b) mobilize the medial piriform sinus mucosae and suture it anteriorly up to the vestibular folds-thus reforming the neo aryepiglottic folds. This leaves very little or no raw area in the supraglottis-thus preventing cicatricial pulling down of the epiglottis.
There are several drawbacks in our study-namely being a retrospective analysis based on clinical presentations and observations during endoscopy. The results need to be confirmed with prospective multi-centric studies involving larger number of patients. We feel that the examination of an awake child done in an outpatient clinic has certain drawbacks-though it is the best way to visualize the upper airway dynamics. With improved anesthesia techniques, the pediatric anesthesiologists of our institution are able to aptly maintain the airway dynamics of a child under general anesthesia, allowing us to evaluate minute details of a floppy airway. Such an examination in an OT set-up eliminates the infants discomfort and the parents stress. Detailed awake and sleep endoscopy of the entire airway can be done during this anesthesia, thus eliminating the effect of troublesome mass pharyngolaryngeal movements that are experienced while examining the child in the outpatient clinic. Additionally, an LSGP can be done if necessary.
Conclusions
LSGP is effective and safe to treat severe LM. Different morphological types of LM require slight surgical variations of LSGP. Optimal treatment requires accurate diagnosis that is best achieved during dynamic transnasal flexible laryngobronchoscopy with the child breathing spontaneously. Our series confirms that prematurity is a risk factor for SGP failure. Using a treatment-oriented classification, we show that type III LM has an increased risk of failure due to high breakdown rate of epiglottopexy. Also, patients with type III LM have an increased incidence of comorbidities (synchronous airway lesions, prematurity and neurological problems) than patients with types I and II LM and hence have poorer prognosis. Larger prospective studies are required to perform multivariate analysis and definitely prove that type III LM is an independent risk factor for SGP failure. Epiglottopexy sutures using conventional needle-carriers are inadequate and prone to pexy breakdown and treatment failure. Our new technique using the Lichtenberger's needle-carrier has improved our epiglottopexy results.
Compliance with ethical standards
Funding None.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval All procedures performed in this study involving human participants were in accordance with the ethical standards of our institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent For this type of study (retrospective study) formal consent is not required.
